Conversely, it is conceivable that expansion of the blood CD34+/CD45dim/CD117+/AnnV- cell compartment may be secondary to increased tumor burden, which may perturbate blood levels of this cell subset [57]. This evidence concerns the gene CD34 and neoplasm.